ArticleBlood cancer journal2026

NFκB/IL-6/JAK2/STAT axis in myelofibrosis is a key vulnerability that is targetable and relevant to JAK2 inhibitor treatment resistance.

Huiqin Bian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.